Moderna, a fresh Sell signal in week 1
Moderna Shares Drop 12.5% as a Fresh Sell Signal Switches On
Moderna, a fresh Sell signal in week 1
Our view last week
Moderna's shares have booked a second heavy drop in a row, 9.4% in five days, after last week's 14.4% slide. The weekly structure still holds: the ADX keeps climbing, a sign the trend isn't losing conviction. The first warning sign comes from volume, with money flow just turning negative and momentum down to its lowest point of the period.
This week's summary
Moderna shares book a second heavy week, down 12.5% in five days, and this time the model's Sell signal switches on. Price carved a double bottom in the 53 area with a 66% intermediate rebound, but the last bar saw sellers come back in extreme force. Signal strength climbs to 100 out of 100: the decline is making lower lows, pace holding. Weekly technical analysis as earnings land this very week.
IQS Phase
55
ordinary
Signal Strength
100
downtrend making lower lows, pace holding
Sizing
STANDARD
Ranking
#6 / 141
New us stocks
Trade P&L %
+0.00%
from signal to today
Rank position
ranks 6th among the 141 sell signals for US stocks in our ranking, with a signal strength of 100 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
MRNA belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content